loading
前日終値:
$10.50
開ける:
$10.66
24時間の取引高:
1.44M
Relative Volume:
0.68
時価総額:
$1.58B
収益:
$177.28M
当期純損益:
$-195.24M
株価収益率:
-7.7537
EPS:
-1.34
ネットキャッシュフロー:
$-114.54M
1週間 パフォーマンス:
-12.10%
1か月 パフォーマンス:
-0.76%
6か月 パフォーマンス:
+52.57%
1年 パフォーマンス:
+145.63%
1日の値動き範囲:
Value
$10.25
$10.77
1週間の範囲:
Value
$10.25
$11.90
52週間の値動き範囲:
Value
$3.845
$12.43

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Name
名前
Adaptive Biotechnologies Corp
Name
セクター
Healthcare (1163)
Name
電話
206-659-0067
Name
住所
1165 EASTLAKE AVE E, SEATTLE, WA
Name
職員
619
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
ADPT's Discussions on Twitter

ADPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADPT
Adaptive Biotechnologies Corp
10.39 1.80B 177.28M -195.24M -114.54M -1.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-18 開始されました Craig Hallum Buy
2025-03-21 アップグレード Goldman Neutral → Buy
2023-07-05 再開されました JP Morgan Overweight
2023-01-05 開始されました Scotiabank Sector Outperform
2022-12-21 アップグレード Piper Sandler Neutral → Overweight
2022-08-25 開始されました Credit Suisse Underperform
2022-06-03 開始されました Piper Sandler Neutral
2022-02-16 繰り返されました BTIG Research Buy
2022-02-16 繰り返されました BofA Securities Buy
2022-02-16 繰り返されました Goldman Neutral
2022-02-16 繰り返されました JP Morgan Overweight
2021-10-15 再開されました Cowen Outperform
2021-03-03 ダウングレード Goldman Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-09-09 開始されました Morgan Stanley Equal-Weight
2020-06-03 開始されました Goldman Buy
2019-07-23 開始されました BTIG Research Buy
2019-07-22 開始されました BofA/Merrill Buy
2019-07-22 開始されました Cowen Outperform
2019-07-22 開始されました Goldman Neutral
2019-07-22 開始されました Guggenheim Buy
2019-07-22 開始されました William Blair Outperform
すべてを表示

Adaptive Biotechnologies Corp (ADPT) 最新ニュース

pulisher
Jul 19, 2025

Principal Financial Group Inc. Purchases 141,691 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Cerity Partners LLC Sells 21,433 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Is Adaptive Biotechnologies Corporation a good long term investmentPhenomenal capital gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Adaptive Biotechnologies Corporation stockSky-high return potential - Jammu Links News

Jul 18, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Acquires New Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Adaptive Biotechnologies Corporation to Announce Second Quarter 2025 Financial Results on August 5, 2025 - Quiver Quantitative

Jul 15, 2025
pulisher
Jul 15, 2025

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

How Adaptive Biotechnologies Corporation stock performs during market volatilityTrade Ready Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Adaptive Biotechnologies Corporation stock price move sharplyHigh Confidence Trade Setups - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Wealth Enhancement Advisory Services LLC Invests $87,000 in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World

Jul 11, 2025
pulisher
Jul 04, 2025

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance

Jul 04, 2025
pulisher
Jul 01, 2025

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR® - Yahoo Finance

Jul 01, 2025
pulisher
Jun 30, 2025

Adaptive Biotechnologies Corporation(NasdaqGS:ADPT) added to Russell 3000 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 26, 2025

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

Adaptive Biotechnologies stock hits 52-week high at 10.88 USD By Investing.com - Investing.com South Africa

Jun 25, 2025
pulisher
Jun 24, 2025

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Jun 24, 2025
pulisher
Jun 21, 2025

Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet - Benzinga

Jun 21, 2025
pulisher
Jun 19, 2025

Rhumbline Advisers Raises Stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Cathie Wood’s ARK buys BWX stock, sells Adaptive Biotech - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Adaptive Biotechnologies (ADPT) Sees Positive Growth Prospects | - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

Adaptive Biotechnologies (ADPT) Receives New Buy Rating and Pric - GuruFocus

Jun 18, 2025
pulisher
Jun 12, 2025

Adaptive Biotechnologies reports annual meeting outcomes By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

Adaptive Biotechnologies reports annual meeting outcomes - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Bought by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Adaptive Biotechnologies at Goldman Sachs Conference: Strong Q1 Performance and Strategic Growth - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

118,593 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Raises Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Nasdaq Today Adaptive Biotechnologies’ Role in Innovation Kalkine - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

ADPT stock soars to 52-week high, hits $10.28 amid surge - Investing.com India

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Has $309,000 Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Has $1.10 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Bank of America Corp DE - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

Cathie Wood’s ARK buys Guardant Health, sells Adaptive Biotechnologies stock - Investing.com Nigeria

Jun 03, 2025
pulisher
May 31, 2025

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 31, 2025
pulisher
May 30, 2025

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration - Benzinga

May 30, 2025
pulisher
May 30, 2025

Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at Key Conferences | ADPT Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers - The Manila Times

May 30, 2025
pulisher
May 30, 2025

Adaptive Biotechnologies’ MRD test featured in cancer studies - Investing.com

May 30, 2025
pulisher
May 30, 2025

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

May 30, 2025
pulisher
May 30, 2025

BNP Paribas Financial Markets Reduces Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

May 30, 2025
pulisher
May 29, 2025

Cathie Wood’s ARK buys CRISPR, sells Adaptive Biotech stock By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Cathie Wood’s ARK buys CRISPR, sells Adaptive Biotech stock - Investing.com

May 29, 2025
pulisher
May 28, 2025

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times

May 28, 2025
pulisher
May 26, 2025

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 26, 2025
pulisher
May 25, 2025

Janus Henderson Group PLC Buys Shares of 46,900 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

May 25, 2025
pulisher
May 20, 2025

Catherine Wood Reduces Stake in Adaptive Biotechnologies Corp - GuruFocus

May 20, 2025

Adaptive Biotechnologies Corp (ADPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
大文字化:     |  ボリューム (24 時間):